Aurora Cannabis (ACB) had the highest return between 2009 and 2022 by a US stock in the Pharmaceuticals Industry, returning 122,966.7%.

ASSET	YEARS	% RETURN
Aurora Cannabis (ACB)	2009-2022	122,966.67%
Jazz Pharmaceuticals (JAZZ)	2009-2022	8,419.25%
Akari Therapeutics (AKTX)	2009-2022	7,420%
TNF Pharmaceuticals (TNFA)	2009-2022	7,141.43%
Corcept Therapeutics (CORT)	2009-2022	1,780.56%
Novo Nordisk A-S (NVO)	2009-2022	1,635.37%
Cronos (CRON)	2009-2022	1,430.12%
Eli Lilly and (LLY)	2009-2022	1,326.4%
Axsome Therapeutics (AXSM)	2009-2022	757%
Dr Reddy’s Laboratories Ltd ADR (RDY)	2009-2022	545.84%
Merck (MRK)	2009-2022	529.17%
AstraZeneca PLC ADR (AZN)	2009-2022	514.24%
Prestige Brand (PBH)	2009-2022	503.81%
Pacira BioSciences (PCRX)	2009-2022	451.57%
Supernus Pharmaceuticals (SUPN)	2009-2022	448.77%
Pfizer (PFE)	2009-2022	413.56%
Zoetis (ZTS)	2009-2022	398.29%
Bristol-Myers Squibb (BMY)	2009-2022	393.86%
Johnson & Johnson (JNJ)	2009-2022	343.55%
ProPhase Labs (PRPH)	2009-2022	309.26%
Amphastar P (AMPH)	2009-2022	300.29%
Novartis AG ADR (NVS)	2009-2022	248.88%
Sanofi ADR (SNY)	2009-2022	169.67%
Oramed Pharmaceuticals (ORMP)	2009-2022	150.63%
SIGA Technologies (SIGA)	2009-2022	135.21%